Transdermal viprostol in the treatment of male pattern baldness.


Journal Article

Fifty-seven men were randomly assigned for treatment of androgenetic alopecia with viprostol, vehicle, or placebo twice daily for 24 weeks. Nonvellus hair growth was assessed subjectively by both patient and investigator and objectively through hair counts from macrophotographs of the target area. Nonvellus target area hair counts declined in all three treatment groups at the end of the 6-month study. Viprostol is not an effective hair growth promoter in androgenetic alopecia.

Full Text

Duke Authors

Cited Authors

  • Olsen, EA; DeLong, E

Published Date

  • September 1990

Published In

Volume / Issue

  • 23 / 3 Pt 1

Start / End Page

  • 470 - 472

PubMed ID

  • 2212146

Pubmed Central ID

  • 2212146

International Standard Serial Number (ISSN)

  • 0190-9622

Digital Object Identifier (DOI)

  • 10.1016/0190-9622(90)70242-a


  • eng

Conference Location

  • United States